Active, Not Recruiting
Daratumumab, Pomalidomide, and Dexamethasone (DPd) in Relapsed/Refractory Light Chain Amyloidosis Patients Previously Exposed to Daratumumab
NCT04270175
- Conditions
- AL Amyloidosis, Alzheimer Disease, Amyloid, +21 more
- Locations
-
- Stanford University Palo Alto, California, United States
- Boston University Medical Center Boston, Massachusetts, United States
- Weill Cornell Medicine - Multiple Myeloma Center New York, United States
- Medical College of Wisconsin Milwaukee, Wisconsin, United States